13G Filing: Perceptive Advisors and Ocera Therapeutics Inc. (OCRX)

Item 1.

(a)

Name of Issuer:

Ocera
Therapeutics, Inc.

(b)

Address
of Issuer’s Principal Executive Offices:

525 University Avenue, Suite 610

Palo Alto, California 94301

Item 2.

(a)

Name of Person Filing:

This
Schedule 13G (the “Schedule”) is being filed with respect to shares of Common
Stock (as defined below) of Ocera Therapeutics, Inc. (the
“Issuer”) which are beneficially owned by Perceptive Advisors LLC, Joseph
Edelman and Perceptive Life Sciences Master Fund, Ltd. (together, the “Reporting
Persons”). See Item 4 below.

(b)

Address
of Principal Business Office or, if none, Residence:

51 Astor Place, 10^th Floor

New York, NY 10003

(c)

Citizenship:

Perceptive Advisors LLC is a Delaware limited liability company, Perceptive Life Sciences Master Fund, Ltd.
is a Cayman Islands corporation and Joseph Edelman is a United States Citizen.

(d)

Title of Class of Securities:

Common
Stock

(e)

CUSIP Number:

67552A108


(a)	o	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
(b)	o	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
(c)	o	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
(d)	o	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8).
(e)	x	An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
(f)	o	An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
(g)	o	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	o	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	o	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	o	Group, in accordance with §240.13d-1(b)(1)(ii)(J).

13G Filing: Perceptive Advisors and Ocera Therapeutics Inc. (OCRX)

Published on April 17, 2017 at 2:06 pm by Insider Monkey Staff in Hedge Funds

Page 5 of 8 – SEC Filing

Follow Ocera Therapeutics Inc. (NASDAQ:OCRX)

Follow Ocera Therapeutics Inc. (NASDAQ:OCRX)

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Published on October 30, 2024 at by Inan Dogan, PhD

A New Dawn is Coming to U.S. Stocks

Published on November 16, 2024 at by Insider Monkey Staff